Universal Health Services Inc offers healthcare services through its behavioral health centers, acute care hospitals, and related outpatient facilities. As of late 2025, the company operated 346 inpatient behavioral health centers, 29 acute care hospitals, and many supportive outpatient facilities.
It is a $10.4B healthcare company. Revenue grew 10.0% over the last year, it keeps 8¢ of every dollar of sales as profit, and its net debt equals ~4.6 years of free cash flow. It trades at 6.8× earnings — near the lowest of its own history.
- Website
- uhs.com
- Location
- King Of Prussia, PA
- Employees
- 101 500
- Sector
- Healthcare
Skills
Six independent scores, 0–100, built from reported numbers and valuation history. Click a row to see how it was scored.
Strong valuation.
Valuation100
- P/E vs own history7th pct · 25/25
- FCF yield8.1% · 25/25
- P/S0.6x · 25/25
- EV/EBITDA5.6x · 25/25
Growth52
- Revenue CAGR8.3% · 12/25
- Net income CAGR10.7% · 20/25
- EPS CAGR ~5Y15.9% · 20/25
- Fwd implied growth-10.0% · 0/25
Profitability57
- ROIC14.5% · 12/25
- ROE20.8% · 20/25
- Net margin8.4% · 13/25
- Operating margin11.4% · 12/25
Health67
- Altman Z2.25 · 18/25
- Current ratio1.12 · 12/25
- Interest coverage13.6x · 25/25
- Net cash / debtD/A 25% · 12/25
Quality60
- Piotroski F8/9 · 25/25
- Beneish M-2.40 · 20/25
- FCF conversion55% · 15/25
- Margin stabilityσ 2428.8% · 0/25
Moat62
- ROIC >12% years4/10 yrs · 6/25
- Median gross margin40.0% · 13/25
- FCF-positive years10/10 yrs · 25/25
- Worst-year net marginworst 5.0% · 18/25
Experience
The company's career so far — founding, the IPO, landmark products and acquisitions, plus revenue milestones and insider buying.
- FY2025FinancialBest year on record$1.49B net income
- Sep 28, 2020ProductUniversal Health Services Inc. announced that its network went offline after an unspecified…
- 2018AcquisitionUHS announced its acquisition of the Danshell Group
- FY2017FinancialRevenue crossed $10B$10.4B for the year
- FY2016FinancialProfitable every year on record10 consecutive profitable years in our data
- FY2016FinancialRevenue already above $1B$9.77B in first reported year
- FY2016FinancialPositive free cash flow every year since10-year streak
- 2016AcquisitionUHS bought Desert View Hospital in Pahrump, Nevada for an undisclosed amount
- 2014AcquisitionUHS bought Palo Verde Mental Health for an undisclosed amount, renaming the facility to Palo Verde…
- 2012AcquisitionUHS announced its plans to acquire Ascend Health Corporation for $517 million
- 2010AcquisitionUHS reached an agreement in May to acquire Psychiatric Solutions, Inc
- 1986ProductUHS created Universal Health Realty Income Trust, the first REIT in the healthcare industry
- 1983AcquisitionUHS purchased Qualicare, Inc. for more than $116 million
- 1982AcquisitionUHS purchased five hospitals from the Stewards Foundation, marking the first time a for-profit corporation…
- 1981IPOUHS held its initial public offering
Achievements
Verifiable track record, straight from the reported numbers.
Strengths & watch-outs
What a bull and a bear would each point to. Both lists come from the reported numbers, not opinions.
Strengths
- Revenue growing 10.0% year over year
- Interest covered 13.6× by operating earnings
- Piotroski F-Score 8/9 — fundamentally strong checklist
Watch-outs
- Net debt would take ~6.1 years of free cash flow to repay
Qualifications
The basics a company should meet before you research it further. Each check uses the reported numbers.
- Revenue growing — the company sells more than a year ago+10.0% YoY
- Profitable — makes more than it spends$1.53B TTM
- Profit growing — earnings are higher than last year+36.1% YoY
- Generates cash — cash left after running and investing$845M TTM
- Debt under control — could handle its obligations~4.6y of cash flow to repay
- Established company — not a micro-cap — lower blow-up risk$10.4B market cap
- Not printing shares — share count not ballooning — you keep your slice-24.7% shares over ~5y
- Proven track record — years of profitability behind it10/10 profitable years
- Financially stable — balance sheet not near distressAltman Z 2.3 — grey
- Pays a dividend — returns cash to shareholdersyield 0.47%
- Valuation not extreme — price not wildly above earningsP/E 6.8
Peer comparisonUniversal Health Services, Inc. vs 6 largest healthcare peers — cap, P/E, growth and margin side by sideOpen ▾Close ▴
| Company | Market cap | P/E | Revenue growth | Net margin | Profile |
|---|---|---|---|---|---|
| UHS this company | $10.4B | 6.8 | +10.0% | 8.4% | Solid |
| LLY Eli Lilly & Co. | $1.0T | 41.6 | +49.6% | 33.5% | Solid |
| JNJ Johnson & Johnson | $630.9B | 29.9 | +8.1% | 21.5% | Mixed |
| ABBV Abbvie Inc. | $488.5B | 77.4 | +10.4% | 9.8% | Mixed |
| MRK Merck & Co., Inc. | $361.0B | 113.2 | +4.6% | 4.8% | Mixed |
| UNH UNITEDHEALTH GROUP INCORPORATED (Delaware) | $340.7B | 24.1 | +6.5% | 3.1% | Mixed |
| NVS Novartis AG | $273.2B | 20.3 | +9.6% | 24.7% | Solid |
Head-to-head: UHS vs LLY · UHS vs JNJ · UHS vs ABBV
References
What covering analysts publish about the company — information only, not a recommendation.
Appendix · Financial records
The full statements behind this CV, FY2016–FY2025. For readers who want to check the numbers.
Live data and quarterly detail: stockcv.com/UHS
Want the live picture — intraday moves, valuation history and full analysis?
Deeper analysis of UHS on PreMarketPriceFigures are derived from company filings (quarterly values normalised from as-filed year-to-date data where applicable) and may be delayed, restated or incomplete. This page is information, not investment advice. Latest price $177.35 · market cap $10.4B.